YouTube

Pediatime Logo

YouTube: Subscribe to Pediatime!

Stay updated with the latest pediatric education videos.

Subscribe Now

Brauer Syndrome (Setleis Syndrome)

Brauer Syndrome (Setleis Syndrome)

Brauer syndrome, also known as Setleis syndrome or focal facial dermal dysplasia type III (FFDD3), is a rare genetic condition characterized by distinctive facial features and dermal abnormalities. It belongs to the group of focal facial dermal dysplasias.

Key Points

  • Rare autosomal recessive inheritance pattern
  • Characterized by distinctive facial features present at birth
  • Associated with TWIST2 gene mutations
  • Part of the focal facial dermal dysplasia spectrum
  • Variable expressivity among affected individuals

Epidemiology

  • Extremely rare disorder with fewer than 50 reported cases
  • Affects males and females equally
  • Higher prevalence in Puerto Rican populations
  • Can occur in any ethnic group

Historical Context

  • First described by Brauer in 1929
  • Further characterized by Setleis in 1963
  • Genetic basis identified in the early 2000s
  • Classification as FFDD3 established in 2011

Clinical Features

Facial Features

  1. Primary Characteristics:
    • Bilateral temporal marks resembling forceps marks
    • Leonine appearance with coarse features
    • Absent or sparse eyelashes
    • Multiple periocular papules
    • Puckered chin
  2. Secondary Features:
    • Upslanting palpebral fissures
    • Flattened nasal bridge
    • Thick vermilion of lips
    • Facial asymmetry
    • Abnormal hair growth patterns

Dermatological Manifestations

  • Skin Findings:
    • Bitemporal scar-like lesions
    • Dermal atrophy or aplasia
    • Abnormal skin texture
    • Altered pigmentation
  • Hair Abnormalities:
    • Sparse or absent eyelashes
    • Abnormal eyebrow patterns
    • Unusual scalp hair distribution
    • Variable body hair patterns

Associated Features

  • Growth and development usually normal
  • Normal intelligence
  • Possible ocular complications
  • Dental anomalies in some cases
  • Potential hearing impairment

Diagnosis & Genetics

Diagnostic Approach

  • Clinical Diagnosis:
    • Based on characteristic facial features
    • Family history assessment
    • Physical examination
    • Documentation of temporal lesions
  • Genetic Testing:
    • TWIST2 gene sequencing
    • Next-generation sequencing panels
    • Whole exome sequencing if needed

Molecular Genetics

  • TWIST2 Gene:
    • Located on chromosome 2q37.3
    • Basic helix-loop-helix transcription factor
    • Role in mesodermal development
    • Multiple pathogenic variants identified
  • Inheritance Pattern:
    • Autosomal recessive transmission
    • Variable expressivity
    • Genetic counseling important

Differential Diagnosis

  • Other focal facial dermal dysplasias
  • Bitemporal aplasia cutis congenita
  • Kabuki syndrome
  • Ablepharon macrostomia syndrome
  • Ectodermal dysplasias

Histopathology

  • Dermal hypoplasia
  • Abnormal collagen organization
  • Reduced elastic fibers
  • Altered appendageal structures

Management

Multidisciplinary Care

  • Core Team Members:
    • Clinical geneticist
    • Dermatologist
    • Plastic surgeon
    • Ophthalmologist
    • Pediatrician
  • Support Services:
    • Genetic counseling
    • Psychological support
    • Social work services
    • Educational support

Treatment Options

  1. Dermatological Care:
    • Skin protection measures
    • Moisturizing regimens
    • Treatment of complications
    • Scar management
  2. Surgical Interventions:
    • Reconstructive procedures
    • Scar revision
    • Aesthetic improvements
    • Timing considerations
  3. Ophthalmologic Care:
    • Regular eye examinations
    • Management of corneal exposure
    • Protection of ocular surface
    • Treatment of complications

Research & Development

Current Research

  • Molecular Studies:
    • TWIST2 function investigation
    • Genetic modifier studies
    • Developmental pathway research
    • Animal models
  • Clinical Research:
    • Natural history studies
    • Treatment outcome analysis
    • Quality of life assessments
    • Genotype-phenotype correlations

Future Directions

  • Gene therapy possibilities
  • Novel treatment approaches
  • Improved diagnostic methods
  • Patient registry development

Prognosis & Care

Long-term Outcomes

  • Normal life expectancy
  • Variable cosmetic concerns
  • Psychosocial challenges
  • Quality of life impact

Monitoring Guidelines

  • Regular Follow-up:
    • Annual genetic assessment
    • Biannual dermatology review
    • Regular ophthalmology checks
    • Developmental monitoring
  • Specific Monitoring:
    • Growth parameters
    • Ocular complications
    • Skin changes
    • Psychosocial adjustment

Support Resources

  • Patient support groups
  • Educational resources
  • Family counseling
  • Community services
Further Reading


Powered by Blogger.